Biond Biologics

Hummingbird Bioscience

This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.

Pandion Therapeutics

The company develops bispecific antibody therapeutics for patients with autoimmune diseases, inflammatory conditions and organ transplants to achieve localised immunomodulation.

Bionyra

This biopharmaceutical company develops monoclonal and bispecific antibodies for patients with severe immune-mediated inflammatory diseases, specifically inflammatory bowel disease and atopic dermatitis.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Radiant Biotherapeutics

This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.

Ankyra Therapeutics

This biotechnology company develops anchored immunotherapy treatments for patients with cancer and other serious immune-mediated diseases.

Solu Therapeutics

This biotechnology company develops antibody-based medicines that target and eliminate disease-driving cells to treat patients with cancer and immunological disorders.

Attovia Therapeutics

The company develops biparatopic biologics to treat patients with immune-mediated diseases and cancer through a modular protein design platform.